CMS publishes final rule on overpayments for Medicare Parts A and B

CMS has published a final rule that requires healthcare providers and suppliers receiving funds from Medicare Part A and Part B to report and return overpayments within 60 days of first identifying them.

“Our general aim of this final rule is to strengthen program integrity and to ensure that the Medicare Trust Funds are protected and made whole and that taxpayer dollars are not wasted,” the final rule stated. “An overpayment must be reported and returned regardless of the reason it happened—be it a human or system error, fraudulent behavior, or otherwise.”

Providers are liable for returning Medicare overpayments dated as far back as six years after the payment was originally received. This is a change from when the rule was first proposed back in 2012; the timeframe then was ten years, not six.

This change, CMS said, came after numerous comments claiming ten years was too long of a lookback period.

“After review of all the issues identified by the commenters, we conclude that a 6-year lookback period would appropriately address many of the concerns about burden and cost outlined previously,” the final rule stated. “Specifically, we note that, according to commenters, many providers and suppliers retain records and claims data for between 6 and 7 years based on various existing federal and state requirements. Thus, we believe our final rule does not create additional burden or cost on providers and suppliers in this regard.”

The rule also addressed the topic of “over-coding,” or “upcoding.” According to CMS, some commenters were unsure if “unintentional” upcoding would be in violation of the rules.

“To clarify, providers and suppliers must report and return overpayments identified as a result of upcoding, whether the inappropriate coding was intentional or unintentional,” the final rule stated.

Other commenters suggested to CMS that the lookback period for overpayments should be the same for underpayments. CMS made it clear that this final rule addresses overpayments, not underpayments, and underpayments have been touched on by previous policies.

A final rule from 2014 addressed the returning of overpayments for Medicare Part C and Part D. That rule can be read, in full, on the U.S. Government Publishing Office website. 

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.